As part of it's initiative for expanded IP technology development, strategic partnering and licensing, PHIGENIX is pleased to announce that we have acquired the services of DLA Piper, LLP. Dr. Carlton D. Donald, President and CEO of PHIGENIX, commented, "Our meeting today with representatives of DLA Piper's Global Life Sciences team was both exciting and encouraging. Their proven track record and experience in counseling clients on strategic patent matters, including patent prosecution, product clearance, patent portfolio mapping, and patent mining evaluations and analyses will be instrumental in assisting Phigenix in reaching its goals." DLA Piper has been named “Game Changer of the Past 10 Years” by Financial Times (2015), and have 34 DLA Piper lawyers from 10 countries recognized as world’s leading patent practitioners by Intellectual Asset Management IAM Patent 1000 (2017), among other distinctions.